ArticleArthritis & rheumatology (Hoboken, N.J.)2019
Limitations in Assessing Cardiovascular Risk of Febuxostat in Patients With Gout and Cardiovascular Morbidities: Comment on the Article by Choi et al.
Aryeh M Abeles et al.PubMed ↗Publisher ↗
No numbers read from the abstract.